LSV Asset Management trimmed its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 27.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,409,736 shares of the pharmacy operator's stock after selling 925,100 shares during the quarter. LSV Asset Management owned 0.28% of Walgreens Boots Alliance worth $22,483,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently made changes to their positions in the company. Swedbank AB increased its stake in Walgreens Boots Alliance by 45.3% during the 4th quarter. Swedbank AB now owns 595,828 shares of the pharmacy operator's stock valued at $5,559,000 after purchasing an additional 185,762 shares in the last quarter. Merit Financial Group LLC bought a new position in Walgreens Boots Alliance in the 4th quarter valued at approximately $326,000. Assenagon Asset Management S.A. boosted its stake in Walgreens Boots Alliance by 2,599.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 622,703 shares of the pharmacy operator's stock valued at $5,810,000 after purchasing an additional 599,637 shares during the last quarter. Orca Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance in the 4th quarter worth $322,000. Finally, Sound Income Strategies LLC raised its stake in shares of Walgreens Boots Alliance by 4.8% in the fourth quarter. Sound Income Strategies LLC now owns 507,213 shares of the pharmacy operator's stock worth $4,732,000 after purchasing an additional 23,373 shares during the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.
Walgreens Boots Alliance Price Performance
NASDAQ WBA traded up $0.05 on Thursday, reaching $10.85. The company had a trading volume of 3,487,757 shares, compared to its average volume of 20,912,114. The firm's 50 day moving average price is $10.80 and its 200 day moving average price is $10.10. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $18.83. The stock has a market capitalization of $9.38 billion, a PE ratio of -1.06, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $38.59 billion for the quarter, compared to the consensus estimate of $37.90 billion. During the same period in the previous year, the business earned $1.20 earnings per share. The firm's revenue for the quarter was up 4.1% on a year-over-year basis. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
Analyst Ratings Changes
A number of equities analysts have recently issued reports on WBA shares. StockNews.com started coverage on Walgreens Boots Alliance in a research note on Friday, April 11th. They issued a "hold" rating on the stock. Truist Financial dropped their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research report on Friday, January 31st. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Royal Bank of Canada raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a report on Wednesday, January 15th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and reduced their target price for the company from $11.00 to $9.00 in a report on Friday, February 28th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $10.59.
Read Our Latest Report on Walgreens Boots Alliance
Walgreens Boots Alliance Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Read More

Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.